"/> Novus Biologicals™ Peptide bloquant d’anticorps IF… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IFITM1

Réf. : BL-RE-104627Réf. fabricant : 18234686 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
8519
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77171. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the center of human IFITM1.

Points forts

Source

Synthetic

(Accession #: NP_003632) The IFITM1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-104627
Réf. fabricant18234686
Gene ID (Entrez)8519
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77171. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCD225 antigen, CD225Leu-13 antigen, IFI17LEU13,9-27, interferon induced transmembrane protein 1 (9-27), Interferon-induced protein 17, interferon-induced transmembrane protein 1, Interferon-inducible protein 9-27
Symbole de gène(s)IFITM1
Type de produitIFITM1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the center of human IFITM1
Une question, une configuration particulière ?
Contactez-nous pour un devis.